Literature DB >> 8786736

Renal handling of carnitine in experimental vitamin C deficiency.

C J Rebouche1.   

Abstract

Experimental vitamin C deficiency is associated with carnitine concentrations in blood and some tissues, but is not due to a decreased ability of scorbutic animals to synthesize carnitine. The effect of experimental vitamin C deficiency on urinary carnitine excretion in vivo and carnitine transport into renal cortical brush-border membrane vesicles in vitro was investigated in guinea pigs fed normal and vitamin C-deficient diets for 24 days. Excretion of free and total carnitine was approximately fourfold greater in scorbutic animals as compared with normal guinea pigs during the last 6 days of the experimental regimen. The rate of carnitine transport into renal cortical brush-border membrane vesicles prepared from scorbutic animals was approximately 36% lower than the corresponding rate for vesicles prepared from normal animals. However, this effect was not specific, since rates of sodium gradient-dependent transport of glucose, lysine, and taurine (but not alanine) were also lower in vesicles prepared from scorbutic animals, although the magnitude of the decrease was less than for carnitine. The results are consistent with the hypothesis that carnitine depletion in vitamin C deficiency is due to decreased efficiency of carnitine reabsorption.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8786736     DOI: 10.1016/0026-0495(95)90087-x

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  3 in total

1.  Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity.

Authors:  Abhishek Katiyar; Cynthia Aaron
Journal:  J Med Toxicol       Date:  2007-09

2.  [Scurvy. A rare differential diagnosis of rheumatic diseases].

Authors:  K Hofheinz; I Ganzleben; S Schliep; J Wacker; G Schett; B Manger
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

3.  Ascorbic Acid Significantly Decreases Creatine Kinase Plasma Levels in an Animal Model of Statin/Fibrate-Induced Myopathy.

Authors:  Mohsen Zabihi; Fatemeh Askarian; Seyedhossein Hekmatimoghaddam; Mohammadreza Rashidi Nooshabadi; Mohammad Sajjad Zabihi; Seyed Ruhollah Mousavinasab
Journal:  Adv Pharmacol Pharm Sci       Date:  2021-12-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.